Extracellular Gal-3 contributes to cancer proliferation, chemotherapeutic resistance, angiogenesis, endothelial adhesion to the distant organs, and metastatic bone destruction throughout prostate cancer progression [3–9]. This evidence concerns the gene LGALS3 and Familial prostate cancer.